医院医药产品领域商业贿赂问题研究

发布时间：2018-05-20 01:14

本文选题：医药产品 + 商业贿赂　；参考：《华北理工大学》2015年硕士论文

【摘要】：医院医药产品领域商业贿赂是指医院中的国家工作人员、非国家工作人员及医务人员,在药品、医疗器械、医用卫生材料等医药产品采购或者使用活动中,利用职务上的便利,索取销售方财物,或者非法收受销售方财物,为销售方谋取利益的行为。医院医药产品商业贿赂是商业贿赂的特殊表现形式,既有商业贿赂的一般特征,同时,在行为主体、表现形式、危害后果等方面有其特殊性。早在2006年中央部署的首次商业贿赂专项治理活动中,医药卫生领域即被列入重点之一。随后,原国家卫生部、国家中医药管理局、最高人民法院、最高人民检察院、国家卫计委先后联合或单独发布文件,指导开展对医药卫生领域商业贿赂的治理,并取得了一定的成效。但近年来,如葛兰素史克案等医院医药产品商业贿赂案件频发,某些医院甚至因为商业贿赂出现塌方式腐败现象,表明医院医药行业商业贿赂的形势依然很严峻。文章分为五个章节。第一章,介绍了文章的选题背景和意义,在借鉴国内外专家学者对医药产品商业贿赂研究的基础上,提出了本文的研究思路、主要内容、结构和研究方案、方法。第二章,阐释了医院医药产品领域商业贿赂发生的主要环节及表现形式,加入实际案例对医药行业商业贿赂问题进行剖析。第三章,对医药产品领域商业贿赂现象进行了归纳分析,总结概括了医药行业商业贿赂的特征及危害,并指出治理的必要性。第四章,提出了医院医药产品领域商业贿赂的治理困境并对其成因进行了分析。第五章,在归纳总结以上内容的基础上,提出多措并举、多管齐下的系统化的综合治理模式,并提出了有待进一步研究的问题。
[Abstract]:Commercial bribery in the field of hospital pharmaceutical products refers to state staff, non-state staff and medical personnel in hospitals who make use of their functions in purchasing or using pharmaceutical products, such as drugs, medical devices, medical and sanitary materials, etc. The act of soliciting property from the seller or illegally accepting the property of the seller in order to obtain benefits for the seller. Commercial bribery of hospital medical products is a special form of commercial bribery, which has the general characteristics of commercial bribery, at the same time, it has its particularity in the aspects of behavior subject, form of expression, harmful consequence and so on. As early as 2006, the medical and health field was listed as one of the top priorities in the first special campaign on commercial bribery deployed by the central government in 2006. Subsequently, the former Ministry of Health, the State Administration of traditional Chinese Medicine, the Supreme people's Court, the Supreme people's Procuratorate and the State Health and Family Planning Commission jointly or separately issued documents to guide the administration of commercial bribery in the field of medicine and health. And achieved certain results. But in recent years, such as GlaxoSmithKline medical products commercial bribery cases occur frequently, some hospitals even because of commercial bribery corruption phenomenon, indicating that the situation of hospital medical industry commercial bribery is still very serious. The article is divided into five chapters. The first chapter introduces the background and significance of this paper. Based on the domestic and foreign experts and scholars' research on commercial bribery of pharmaceutical products, this paper puts forward the research ideas, main content, structure, research scheme and methods. The second chapter explains the main links and manifestations of commercial bribery in the field of hospital pharmaceutical products, and analyzes the issue of commercial bribery in pharmaceutical industry by adding practical cases. The third chapter summarizes the phenomenon of commercial bribery in the field of pharmaceutical products, summarizes the characteristics and harm of commercial bribery in pharmaceutical industry, and points out the necessity of governance. The fourth chapter puts forward the governance dilemma of commercial bribery in the field of hospital pharmaceutical products and analyzes its causes. The fifth chapter, on the basis of summarizing the above contents, puts forward a systematic and comprehensive management model with multi-measures and multi-pronged approaches, and puts forward some problems to be further studied.
【学位授予单位】：华北理工大学
【学位级别】：硕士
【学位授予年份】：2015
【分类号】：D924.3

【相似文献】